IBRX
ImmunityBio, Inc.
+0.73 (+9.23%)8.64USD9.8M成交股數9.2B市值–本益比(近四季)55.2股價營收比+93.9%營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 51.2M+210% | 44.2M+485% | 32.1M+425% | 26.4M+2424% | 16.5M+41193% | 7.6M+9110% | 6.1M+14793% | 1.0M+191% | 40K | 82K | 41K | 360K |
| 營業成本 | 298K | 238K | 177K | 136K | 58K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – |
| 毛利 | 50.9M+210% | 44.0M+482% | 31.9M+422% | 26.3M+2411% | 16.5M+41048% | 7.6M+9110% | 6.1M+14793% | 1.0M | 40K | 82K | 41K | – |
| 毛利率 | 99.4% | 99.5% | 99.4% | 99.5% | 99.6% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – |
| 研發費用 | – | – | – | – | – | 35.2M | 50.4M | 51.1M | 53.4M | 48.4M | 53.2M | 79.3M |
| 銷售管理費用 | – | – | – | – | – | 41.7M | 35.9M | 49.3M | 41.9M | 31.8M | 32.0M | 32.7M |
| 營業利益 | −61.7M-4% | −69.8M+1% | −55.6M-31% | −71.3M-28% | −64.4M-32% | −69.4M-13% | −80.3M-6% | −99.3M-11% | −95.2M | −80.1M | −85.1M | −112M |
| 營業利益率 | -120.4% | -157.9% | -173.5% | -269.8% | -390.1% | -919.0% | -1,314.3% | -9,487.4% | -237,990.0% | -97,726.8% | -207,670.7% | -30,994.4% |
| 稅後淨利 | −230M+78% | −633M+969% | −67.3M-22% | −92.6M-31% | −130M-3% | −59.2M-38% | −85.7M-38% | −135M+16% | −134M | −95.6M | −138M | −116M |
| 淨利率 | -449.6% | -1,431.4% | -209.8% | -350.3% | -784.9% | -783.9% | -1,404.0% | -12,852.3% | -335,272.5% | -116,563.4% | -336,290.2% | -32,317.5% |
| 稀釋 EPS | -0.22+47% | -0.62+675% | -0.07-50% | -0.10-50% | -0.15-25% | -0.08-58% | -0.14-56% | -0.20-26% | -0.20 | -0.19 | -0.32 | -0.27 |
| 稀釋股數 | 1.05B | 1.03B | 947M | 888M | 853M | 700M | 698M | 687M | 673M | 498M | 437M | 428M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 75.7M | 205M | 60.2M | 138M | 60.7M | 143M | 112M | 130M | 133M | 178M | 43.5M | 88.5M |
| 應收帳款 | 53.5M | 43.3M | 32.0M | 22.1M | 17.0M | 2.4M | 4.2M | 1.0M | – | – | – | – |
| 存貨 | 1.9M | 547K | 6.7M | 6.6M | 8.4M | 8.3M | 2.0M | 1.8M | – | – | – | – |
| 總資產 | 629M | 647M | 519M | 402M | 304M | 383M | 365M | 444M | 401M | 432M | 291M | 343M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 1.7B | 1.5B | 1.0B | 972M | 894M | 871M | 1.1B | 1.1B | 1.1B | 843M | 936M | 875M |
| 股東權益 | −1.0B | −870M | −524M | −571M | −591M | −489M | −745M | −698M | −692M | −412M | −642M | −529M |
| 負債比 | 266.4% | 234.4% | 200.9% | 241.7% | 294.4% | 227.5% | 304.1% | 257.0% | 272.5% | 195.0% | 321.5% | 254.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −75.4M | – | – | −85.9M-20% | – | – | – | −107M | – | – | −84.3M |
| 資本支出 | – | 1.8M | – | – | 1.1M | – | – | – | 1.3M | – | – | 8.4M |
| 自由現金流 | – | −77.1M | – | – | −87.0M-20% | – | – | – | −108M | – | – | −92.7M |
| 折舊攤銷 | – | 4.4M | – | – | 3.8M | – | – | – | 4.6M | – | – | 4.7M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -174.5% | – | – | -526.9% | – | – | – | -270,607.5% | – | – | -25,760.6% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 113M
| Reportable | 113M | 100.0% | +668.3% |
|---|
產品／服務2025 年度 · 113M
| 產品 | 113M | 99.7% | +698.5% |
|---|---|---|---|
| Product And Service Other | 306K | 0.3% | -48.6% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 113M | +668.3% | −352M | -310.3% | -0.38 | −309M |
| FY2024 | 14.7M | +2270.6% | −414M | -2,805.0% | -0.62 | −398M |
| FY2023 | 622K | +159.2% | −584M | -93,874.6% | -1.15 | −397M |
| FY2022 | 240K | -74.3% | −417M | -173,875.0% | -1.04 | −416M |
| FY2021 | 934K | +54.4% | −350M | -37,451.8% | -0.89 | −308M |
| FY2020 | 605K | -72.5% | −222M | -36,669.6% | -0.59 | −173M |
| FY2019 | 2.2M | +4585.1% | −158M | -7,165.2% | -0.43 | −156M |
| FY2018 | 47K | – | −96.2M | -204,736.2% | -1.22 | −76.5M |